NuTech Inc is a US-based company operating in industry. The company is headquartered in Tyler, Texas. NuTech, Inc. is an independently owned, commercial nuclear and infusion pharmacy corporation operating pharmacies in Tyler, College Station and Wichita Falls, Texas. The company offers a range of products, which include Tc-99m Unit Dose Radiopharmaceuticals, Other Unit Dose Radiopharmaceuticals, Adjunctive Pharmaceuticals, and Interventional Agents. Its Tc-99m Unit Dose Radiopharmaceuticals offers Albumin Aggregated (MAA), Bicisate (Neurolite), Exametazime (Ceretec), Medronate (MDP), Mebrofenin (Choletec), Oxidronate (HDP), Pyrophosphate (PYP), and others. Its Other Unit Dose Radiopharmaceuticals offers Carbon-14 Urea (PYtest Kit), Capromab pendetide (Prostascint), F-18 Fluorodeoxyglucose, Gallium-67, and others. Its Adjunctive Pharmaceuticals and Interventional Agents offers Adenosine (Adenoscan), Regadenoson (Lexiscan), Aminophylline Injection, Sincalide (Kinevac Injection), Dipyridamole, Dobutamine Injection, and Ultratag RBC Kit.
Westinghouse Air Brake Technologies Corp 주요 수익원은 Freight Segment이며, 최신 수익 발표에서 수익은 1,543,098,000입니다. 지역별로는 North America이 Westinghouse Air Brake Technologies Corp의 주요 시장이며, 수익은 6,192,000,000입니다.
NuTech Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Westinghouse Air Brake Technologies Corp의 순손실은 $0입니다.
NuTech Inc에 부채가 있나요?
no, Westinghouse Air Brake Technologies Corp의 부채는 0입니다.
NuTech Inc의 발행 주식은 몇 주인가요?
Westinghouse Air Brake Technologies Corp의 총 발행 주식은 0주입니다.